Weight Loss Risk Assessment Form
  • Weight Loss Risk Assessment Form

  • About You

  • Date of Birth*
     - -
  • Gender*
  • What is your ethnicity?*
  • About your health

  • Do you have any of the following conditions?(please tick all that apply)*
  • Do you have any of the following conditions? (please tick all that apply)*
  • Have you ever had an allergic reaction to Wegovy, Semaglutide, Mounjaro, Tirzepatide, Saxenda, Liraglutide, Orlistat, Xenical, or their excipients listed in the SPC?*
  • If female: Are you currently pregnant?*
  • If female: Are you currently breastfeeding?*
  • Are you currently trying to conceive?*
  • Are you currently taking any medication (including over the counter, prescription or recreational drugs)?*
  • Are you taking any of the following medications? (please tick all that apply)*
  • Step Up or Maintenance dose

  • Are you currently taking any of the following weight loss medications: Orlistat, Mysimba, GLP-1 receptor agonists: Wegovy, Mounjaro, Semaglutide, Saxender or Liragluride)?*
  • If Yes, to the above and you have previously started treatment or got the supply elsewhere are you able to provide proof of previous use for example: prescription, label, dispatch note or receipt)?*
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Please provide the date you started taking GLP-1 treatment?
     - -
  • Have you experienced any of the following side effects? (please tick all that apply)
  • Have you been appropriately titrated on the medication in line with the relevant Summary of Product Characteristics (SPC) or protocol, and are you following the correct injection schedule?
  • Is there a gap (not using the medication more than 4 weeks) in the continuity of your medication supply?
  • Acknowledgement

  • Do you understand that you will be required to have a video or a face to face consultation with our clinician before the medication can be supplied?*
  • Do you understand that GLP-1 injectable weight-loss medication (e.g. Mounjaro and Wegovy) may reduce the effectiveness of oral contraceptives and that you must use additional contraceptive measures, such as a barrier method (e.g. condoms), or switching to a non-oral form of contraception (e.g. IUD's and implants) for 4 weeks after initiating Mounjaro and for 4 weeks following each dose increase.*
  • Do you understand that GLP-1 injectable weight-loss medication should not be used by men or women that are either trying to conceive or are within two months of starting to try for a child?*
  • Do you understand the risk of pancreatitis, gall bladder issues, and gallstones associated with these medications, and that abdominal pain should be reported to a doctor?*
  • Do you understand that injectable weight-loss medications should not be used in combination with other weight-loss medications?*
  • Do you understand that if you develop neck lumps or a hoarse voice while using this medication, you should stop and contact your doctor?*
  • Do you understand both weight loss and injectable weight loss treatment have been associated with lowering of mood, if experiencing depression, thoughts of self harm or other menta health issues, you should seek medical advice*
  • Can we share this information with your General Practitioner? Providing us with your GP's address means that you allow us to share this information with him/her for updated medical records if need be. It also allows our clinician to access your medical records if there is a need for that. We would require you share this treatment with your doctor for him/her to update your medical records*
  • Do you agree to the following?

  • You are aware that GLP-1 receptor agonists can lower your blood sugar, increasing the risk of hypoglycemia*
  • You have answered truthfully to all the questions and you are aware that any incorrect information you provided can present a potential danger to your health*
  • You understand prescribing decisions will be based on the answers from your consultation and incorrect information can cause harm to your health. Orders may be rejected if not clinically suitable*
  • You will inform your doctor about any unusual side effects*
  • The treatment is solely for your own use*
  • You will read the patient information leaflet supplied with your medication and understands the titration schedule, actions to take if a dose is missed, correct self-injection technique, and proper storage requirements for the medication*
  • You will not exceed the maximum prescribed dose*
  • You understand that you should follow up with your GP at least once annually for ongoing monitoring and care*
  • You confirm you have the capacity to make decisions about your own health*
  •   .  

     

  • Should be Empty: